Nizoral Scalp Itch Relief Liquid
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| (11bêta)-11,17,21-trihydroxy-prégn-4-ène-3,20-dione Source : Hydrocortisone | 1 % |
Non-medicinal ingredients
Aqua, Acide hyaluronique, Menthol, Jus de feuilles d'Aloe Barbadensis, Glycérine, Acétate de tocophéryle, Ethanol, Phénoxyéthanol, Poly(sorbate) 80, PEG-12 diméthicone, EDTA de disodium, Ethylhexylglycérine, Dipropylène glycol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
| Enfants et Adolescents | minimum: 2 years ; maximum: 17 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Anti-itch. Anti-pruritic. For temporary relief of minor skin irritations (associated with redness, itching, dryness and scaling). For temporary relief of scalp itch from seborrheic dermatitis, psoriasis and eczema. Temporarily relieves itching associated with minor skin irritation, inflammation and rashes due to eczema, psoriasis, seborrheic dermatitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Nizoral Scalp Itch Relief Liquid - Maximum Strength
- Licence holder
- Kramer Laboratories, Inc.
- NPN or DIN-HM
- 80142974
- Status
- Active licence
- Licence date
- 28 July 2025
- Revision date
- 8 April 2026
- Form
- Solution
- Route of administration
- Topique
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80142974
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Nizoral Scalp Itch Relief Liquid (Kramer Laboratories, Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80142974-nizoral-scalp-itch-relief-liquid, updated 8 April 2026.